You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 10, October 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Book and New Media Reviews
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Genital Dermatology Atlas

Edited by Libby Edwards, 253 pp, $99, ISBN 0-7817-5307-4, Philadelphia, Pa, Lippincott Williams & Wilkins, 2004.

Arch Dermatol. 2005;141:1328.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

At first blush, this is an impressively and elegantly printed, moderately priced book with wonderful color pictures of many genital dermatoses. The initial predominance of the female rather than the male genitalia in these illustrations is forgiven as one turns each page to see yet another well-defined and explicit photograph.

It is only when one reads the text more closely that one discovers a number of unnecessary errors and inconsistencies, particularly related to therapy, although none of those that I noticed will lead to serious mismanagement. For example, tacrolimus is not a monoclonal antitumor necrosis factor antibody. Also, fluconazole as a second-line therapy for tinea cruris may not be as effective as itraconazole or terbinafine.

In one chapter, the Centers for Disease Control and Prevention recommendation of 2.4 million U of benzathine penicillin G intramuscularly, given as a single injection for the treatment of early syphilis, is reported correctly, but . . . [Full Text of this Article]

Anne Laumann, MBChB, MRCP(UK), Reviewer



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.